Cargando…
Genome‐Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment
Hepatocellular carcinoma (HCC) is the second most lethal cancer worldwide. Glutamine is an essential, extracellular nutrient which supports HCC growth. Dietary glutamine deficiency may be a potential therapeutic approach for HCC. HCC cells overcome metabolic challenges by rewiring their metabolic pa...
Autores principales: | Yang, Chunxue, Lee, Derek, Zhang, Misty Shuo, Tse, Aki Pui‐Wah, Wei, Lai, Bao, Macus Hao‐Ran, Wong, Bowie Po‐Yee, Chan, Cerise Yuen‐Ki, Yuen, Vincent Wai‐Hin, Chen, Yiling, Wong, Carmen Chak‐Lui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731711/ https://www.ncbi.nlm.nih.gov/pubmed/36310121 http://dx.doi.org/10.1002/advs.202202104 |
Ejemplares similares
-
Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer
por: Cheu, Jacinth Wing-Sum, et al.
Publicado: (2023) -
Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer
por: Zhang, Misty Shuo, et al.
Publicado: (2022) -
Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development
por: Cheu, Jacinth Wing-Sum, et al.
Publicado: (2023) -
Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
por: Wei, Lai, et al.
Publicado: (2019) -
CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma
por: Chan, Cerise Yuen-Ki, et al.
Publicado: (2022)